title: Controlling the diameter, monodispersity, and solubility of ApoA1 nanolipoprotein particles using telodendrimer chemistry.
abstract: Nanolipoprotein particles (NLPs) are nanometer-scale discoidal particles that feature a phospholipid bilayer confined within an apolipoprotein "scaffold," which are useful for solubilizing hydrophobic molecules such as drugs and membrane proteins. NLPs are synthesized either by mixing the purified apolipoprotein with phospholipids and other cofactors or by cell-free protein synthesis followed by self-assembly of the nanoparticles in the reaction mixture. Either method can be problematic regarding the production of homogeneous and monodispersed populations of NLPs, which also currently requires multiple synthesis and purification steps. Telodendrimers (TD) are branched polymers made up of a dendritic oligo-lysine core that is conjugated to linear polyethylene glycol (PEG) on one end, and the lysine "branches" are terminated with cholic acid moieties that enable the formation of nanomicelles in aqueous solution. We report herein that the addition of TD during cell-free synthesis of NLPs produces unique hybrid nanoparticles that have drastically reduced polydispersity as compared to NLPs made in the absence of TD. This finding was supported by dynamic light scattering, fluorescence correlation spectroscopy, and cryo transmission electron microscopy (Cryo-EM). These techniques demonstrate the ability of TDs to modulate both the NLP size (6-30 nm) and polydispersity. The telodendrimer NLPs (TD-NLPs) also showed 80% less aggregation as compared to NLPs alone. Furthermore, the versatility of these novel nanoparticles was shown through direct conjugation of small molecules such as fluorescent dyes directly to the TD as well as the insertion of a functional membrane protein.
authors.affiliation: NSF Center for Biophotonics Science and Technology, Sacramento, California, 95817, USA.
authors.forename: Wei
authors.initials: W
authors.lastname: He
authors.forename: Juntao
authors.initials: J
authors.lastname: Luo
authors.forename: Feliza
authors.initials: F
authors.lastname: Bourguet
authors.forename: Li
authors.initials: L
authors.lastname: Xing
authors.forename: Sun K
authors.initials: SK
authors.lastname: Yi
authors.forename: Tingjuan
authors.initials: T
authors.lastname: Gao
authors.forename: Craig
authors.initials: C
authors.lastname: Blanchette
authors.forename: Paul T
authors.initials: PT
authors.lastname: Henderson
authors.forename: Edward
authors.initials: E
authors.lastname: Kuhn
authors.forename: Mike
authors.initials: M
authors.lastname: Malfatti
authors.forename: William J
authors.initials: WJ
authors.lastname: Murphy
authors.forename: R Holland
authors.initials: RH
authors.lastname: Cheng
authors.forename: Kit S
authors.initials: KS
authors.lastname: Lam
authors.forename: Matthew A
authors.initials: MA
authors.lastname: Coleman
mesh_terms: D016632:Apolipoprotein A-I / Q000737:chemistry* / Q000378:metabolism; D002474:Cell-Free System; D020285:Cryoelectron Microscopy / Q000379:methods*; D050091:Dendrimers / Q000737:chemistry; D008565:Membrane Proteins / Q000737:chemistry / Q000378:metabolism; D053758:Nanoparticles / Q000737:chemistry*; D015202:Protein Engineering; D013050:Spectrometry, Fluorescence / Q000379:methods*
chemical_list: D016632:Apolipoprotein A-I; D050091:Dendrimers; D008565:Membrane Proteins
keywords: apolipoprotein; cell-free expression; membrane protein; mono-dispersity; nanolipoproteins; nanotechnology; telodendrimer